300937 药易购
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.332-1.5451.5557.1375.293
总资产报酬率 ROA (%)-0.151-0.7500.7793.6313.024
投入资产回报率 ROIC (%)-0.189-0.9170.9384.3363.609

边际利润分析
销售毛利率 (%)10.15210.4168.9358.2977.947
营业利润率 (%)0.2550.2000.2271.5481.189
息税前利润/营业总收入 (%)0.4260.3690.4741.7351.315
净利润/营业总收入 (%)0.106-0.3690.2501.2810.910

收益指标分析
经营活动净收益/利润总额(%)510.062457.818259.341122.624138.563
价值变动净收益/利润总额(%)13.610-5.063-9.2582.204-9.559
营业外收支净额/利润总额(%)-0.755-24.29016.7071.837-5.089

偿债能力分析
流动比率 (X)1.4591.5511.6361.7181.679
速动比率 (X)1.0040.9151.0131.0181.085
资产负债率 (%)57.62153.63950.86049.25948.482
带息债务/全部投入资本 (%)43.40040.10337.76137.49937.446
股东权益/带息债务 (%)127.548145.835159.548161.034163.250
股东权益/负债合计 (%)75.08288.83797.346102.791105.482
利息保障倍数 (X)2.4691.7742.34510.9947.147

营运能力分析
应收账款周转天数 (天)22.15613.32711.7447.8194.393
存货周转天数 (天)47.78349.52348.74944.66045.077